Latest Leadership News

Vault Minerals reports a robust FY25 with A$1.43 billion revenue and a net profit of A$237 million, driven by full-year integration of Silver Lake Resources and operational advances. The company outlines a strategic two-stage expansion at King of the Hills and maintains a strong cash position post debt repayment.

Finbar Group Limited reported a robust 46% increase in revenue to $284.5 million for FY2025, despite a 12.5% decline in comprehensive profit. The company completed key residential projects and sharpened its focus on core property development in Western Australia.

Fisher & Paykel Healthcare has issued strong first half FY26 guidance, forecasting significant revenue and profit growth while navigating new US tariffs. Meanwhile, director Pip Greenwood announces her retirement after eight years on the board.

Turners Automotive Group has reported a record FY25 financial performance, with net profit after tax rising 17% to $38.6 million and dividends increasing 14% to 29.0 cents per share, underscoring resilience amid a challenging New Zealand economy.

Auckland International Airport reported a 12% revenue increase to NZD 1 billion and a 12% rise in underlying profit, driven by growing passenger numbers and strong commercial performance. The airport is progressing a major infrastructure program while achieving significant emissions reductions.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Astron Corporation Limited is set to redomicile from Hong Kong to Australia through a scheme of arrangement, creating a new Australian parent company, Aus NewCo. This move aims to align the corporate structure with its Australian assets and simplify shareholder voting.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.

Alliance Aviation Services Limited reported a 19% revenue increase to $760.9 million in FY2025, while net profit after tax slipped 5% to $57.3 million amid operational challenges. The company declared a fully franked dividend of 3.0 cents per share and expanded its fleet to 79 aircraft.

Harmoney Corp has delivered a record FY25 performance, exceeding profit expectations and boosting its FY26 profit forecast by 20%, driven by strong loan growth and its advanced Stellare 2.0 platform.

Genetic Technologies Limited has emerged from voluntary administration following a strategic asset sale and is now pursuing recapitalisation and acquisitions to restore its market position.

Genetic Technologies Limited reports a 36% increase in half-year losses amid voluntary administration, followed by a recapitalisation and sale of core assets. The company pivots towards new financial services acquisitions under fresh leadership.